Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Study Confirms Natalizumab Efficacy, Safety in Treating RRMS
The impact of multiple sclerosis severity on health state utility values: Evidence from Australia.
Intra-CNS activation by antigen-specific T lymphocytes in experimental autoimmune encephalomyelitis.
Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change?
Reassembly of Excitable Domains after CNS Axon Regeneration.
Neuromuscular Disease in the Neurointensive Care Unit.
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.
Development and Validity of Western University's On-Road Assessment.
Web-based physiotherapy for people moderately affected with Multiple Sclerosis; quantitative and qualitative data from a randomized, controlled pilot study.
Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development.
Multiple sclerosis lesion in the medulla oblongata in a patient with takotsubo cardiomyopathy.
Vitamin D status is negatively correlated with retinal nerve fiber layer thickness in relapsing-remitting MS patients without acute optic neuritis.
Acoustic variation during passage reading for speakers with dysarthria and healthy controls.
Transcriptomic analyses of genes and tissues in inherited sensory neuropathies.
Vitamin D level status in Thai neuromyelitis optica patients.
A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons.
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation.
Increased structural white and grey matter network connectivity compensates for functional decline in early multiple sclerosis.
Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals.
Neurotherapeutic Strategies for Multiple Sclerosis.
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol.
Thermal patterns in zoster.
Severe, Highly Active, or Aggressive Multiple Sclerosis.
Pages
« first
‹ previous
…
696
697
698
699
700
701
702
703
704
…
next ›
last »